RxPG - the perfect Rx for medical Post Graduate entrance blues!
Mobile Edition | Help/Newbie? | 24/7 Support
HOT | PrePG | MCQ | DNB | Careers | Books | Colleges | Dental | DocIndia | PLAB |  USMLE  | Australia | Canada | GLOBAL | OffBeat!
Articles | Forums | MCQ Crammer | Downloads | Mnemonics | Revision Tools | Recent Shouts | All Features


PLAB Part 1 Drug Reviews
PLAB Part 1 Section - PLAB 1 - Part 1 of Professional and Linguistic Assessments Board Exam Conducted by GMC, UK Forum - PLAB Part 1 Books
What is new in BNF 52?
by BNF - 13887 reads, based on 7 votes
Long-acting beta2 agonists The safety of long-acting beta2 agonists has come under close scrutiny, particularly following the recent publication of a meta-analysis (Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006; 144: 904912). BNF 52 includes advice developed with the Commission on Human Medicines on the safe use of formoterol and salmeterol (section 3.1.1.1). It is important that use of a long-acting beta2 agonist accords with the guidance on stepwise management of chronic asthma (section 3.1) and that the drug is withdrawn in the absence of benefit.... More


Go to PLAB Part 1 Section
Server Status: 81 pages served in last minute. Page generation time: 0.029 seconds

Site Maps: [Books] [News] [Forums] [Reviews] [Mnemonics]

sitemap - top30 - centuries - testimonials


About Us :: Disclaimer :: Contact Us :: Reporting abuse :: Terms of Services :: Privacy Policy

Advertise with RxPG!
Made in India by RxPG Medical Solutions Private Limited

"RxPG" is a Registered Trademark

Chrome Web Store YouTube Twitter LinkedIn Wikipedia Facebook